CTRI/2015/09/006174已完成未知
Efficacy of ACE inhibitors in anthracycline-induced cardiotoxicity: a double blind placebo controlled randomised controlled trial
Institute of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Confirmed diagnosis of acute lymphoblastic leukemia, hodgkin and non hodgkin lymphoma
- •2. Patients receiving anthracyclines
排除标准
- •1. Relapsed disease
- •2. Previously treated disease
- •3. Pre existing cardiac disease
- •4. Pre existing renal disease
- •5. Pre existing hepatic disease
研究者
相似试验
进行中（未招募）
不适用
Prevention of anthracycline-induced cardiotoxicity: a multicentre randomizedtrial comparing two therapeutic strategies.EUCTR2012-002248-26-ITISTITUTO EUROPEO DI ONCOLOGIA
已完成
不适用
A cohort study of anthracycline-induced cardiotoxicityAll patients scheduled for anthracycline-containing therapy for various kinds of tumorsJPRN-UMIN000022984niversity of Tsukuba500
已完成
不适用
Endothelial function after anthracycline treatment.NL-OMON46659niversitair Medisch Centrum Utrecht20
已完成
不适用
Primary Prevention of Anthracycline-induced Cardiotoxicity with L-Carnitine in patients with breast Cancer (PPACC): pilot studyBreast CancerCancerISRCTN32332192niversity of Ottawa Heart Institute (Institut de cardiologie de l'Université d'Ottawa) (Canada)144
进行中（未招募）
1 期
ACE-EPIC: ACE inhibitors to enhance the effect of pulmonary rehabilitation in COPDCOPDMedDRA version: 14.1 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-000413-36-GBImperial College80